SeraCare Life Sciences Inc announces that the company has developed a new series of controls in its ACCURUN portfolio to monitor and validate molecular diagnostic test performance for detection of Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG).
Read More
Bender MedSystemsBiocare MedicalBiotageDakoG-BiosciencesGreiner Bio-One GmbH
Read MoreDr Breck O. Parker, formerly a Strategic Development Leader for GE Healthcare-Life Sciences Consumables Division, joined the EnviroLogix team on July 1 as Vice President, Molecular Diagnostic Product Development.
Read MoreOncimmune (USA) LLC, provider of EarlyCDT-Lung, announces the publication of a study that demonstrates the clinical validity of the test.
Read MoreA joint statement, by the National Coordinator for Health Information Technology, David Blumenthal, MD, MPP, and the Centers for Medicare & Medicaid Services Principal Deputy Administrator Marilyn Tavenner, was recently issued.
Read More